Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: PPAR signaling pathway (mmu03320)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Acaa1a
KLA  ATP  ATP+KLA
 NM_130864 acetyl-Coenzyme A acyltransferase 1A (Acaa1a), mRNA [NM_130864] KLA 1.53 1.60 1.88 2.07 2.41 2.64 1.82
ATP 1.07 .99 .98 1.10 .94 .83 1.58
KLA/ATP 1.64 1.64 1.73 1.75 1.61 1.39 1.85
Acaa1b
KLA  ATP  ATP+KLA
 NM_146230 acetyl-Coenzyme A acyltransferase 1B (Acaa1b), mRNA [NM_146230] KLA 1.52 1.66 1.93 2.04 2.32 2.51 1.83
ATP 1.04 .95 1.06 1.12 1.03 .93 1.59
KLA/ATP 1.76 1.72 1.76 1.95 1.76 1.51 1.86
Acadl
KLA  ATP  ATP+KLA
 NM_007381 acyl-Coenzyme A dehydrogenase, long-chain (Acadl), nuclear gene encoding mitochondrial protein, mRNA [NM_007381] KLA 1.67 1.61 2.27 1.98 1.98 1.62 .89
ATP 1.24 1.19 1.25 1.30 1.36 1.15 .69
KLA/ATP 1.83 1.95 2.01 2.22 1.71 1.18 .84
Acadm
KLA  ATP  ATP+KLA
 NM_007382 acyl-Coenzyme A dehydrogenase, medium chain (Acadm), nuclear gene encoding mitochondrial protein, mRNA [NM_007382] KLA .57 .50 .50 .37 .34 .34 .54
ATP 1.09 1.08 1.16 .92 .67 .43 .51
KLA/ATP .55 .56 .57 .46 .41 .36 .29
Acox1
KLA  ATP  ATP+KLA
 NM_015729 acyl-Coenzyme A oxidase 1, palmitoyl (Acox1), mRNA [NM_015729] KLA .79 .81 .78 .68 .66 .69 .82
ATP .97 1.09 .93 .90 .81 .78 1.22
KLA/ATP .81 .82 .69 .68 .59 .70 .88
Acox2
KLA  ATP  ATP+KLA
 NM_053115 acyl-Coenzyme A oxidase 2, branched chain (Acox2), mRNA [NM_053115] KLA .99 1.04 1.04 1.06 1.01 1.01 .99
ATP 1.06 1.08 .97 1.04 1.02 1.00 1.02
KLA/ATP 1.07 1.05 1.03 1.01 1.01 1.04 1.02
Acox3
KLA  ATP  ATP+KLA
 NM_030721 acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), mRNA [NM_030721] KLA .56 .56 .63 .55 .50 .48 .68
ATP 1.10 1.00 .85 .76 .87 .44 .73
KLA/ATP .61 .66 .57 .49 .57 .48 .47
Acsbg1
KLA  ATP  ATP+KLA
 NM_053178 acyl-CoA synthetase bubblegum family member 1 (Acsbg1), mRNA [NM_053178] KLA .54 .60 .46 .48 .43 .54 .84
ATP .93 .86 .66 .53 .41 .96 1.25
KLA/ATP .60 .52 .44 .39 .38 .67 1.36
Acsbg2
KLA  ATP  ATP+KLA
 NM_001039114 acyl-CoA synthetase bubblegum family member 2 (Acsbg2), mRNA [NM_001039114] KLA .96 .99 1.05 1.00 .98 1.02 1.03
ATP 1.03 1.02 1.04 .97 1.00 1.03 .96
KLA/ATP 1.02 .98 .99 1.00 .92 1.00 .98
Acsl1
KLA  ATP  ATP+KLA
 NM_007981 acyl-CoA synthetase long-chain family member 1 (Acsl1), mRNA [NM_007981] KLA 6.45 6.43 6.31 6.46 7.76 10.38 13.72
ATP 1.02 1.14 1.04 1.69 2.56 4.02 2.69
KLA/ATP 6.36 6.25 5.41 6.54 4.81 4.79 9.93
Acsl3
KLA  ATP  ATP+KLA
 NM_001033606 acyl-CoA synthetase long-chain family member 3 (Acsl3), transcript variant 2, mRNA [NM_001033606] KLA .29 .27 .29 .29 .30 .32 .39
ATP 1.06 .98 1.19 1.92 2.34 .67 .75
KLA/ATP .27 .26 .39 .88 1.31 .50 .24
Acsl4
KLA  ATP  ATP+KLA
 NM_207625 acyl-CoA synthetase long-chain family member 4 (Acsl4), transcript variant 1, mRNA [NM_207625] KLA 1.16 1.03 1.01 1.21 1.21 1.51 1.70
ATP .89 .88 1.64 1.60 2.24 5.91 2.42
KLA/ATP .92 1.00 1.90 1.71 1.83 3.23 3.56
Acsl5
KLA  ATP  ATP+KLA
 NM_027976 acyl-CoA synthetase long-chain family member 5 (Acsl5), mRNA [NM_027976] KLA 1.32 1.46 1.54 1.51 2.04 2.20 2.31
ATP 1.02 1.10 .89 1.03 .92 .84 .99
KLA/ATP 1.42 1.54 1.17 1.29 .97 1.11 1.35
Acsl6
KLA  ATP  ATP+KLA
 AK147421 adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1038B08 product:acyl-CoA synthetase long-chain family member 6, full insert sequence [AK147421] KLA 1.00 .97 1.02 .99 .97 1.02 1.03
ATP .97 .96 .95 .97 1.00 1.03 1.04
KLA/ATP .99 .96 1.08 .96 1.01 .96 1.00
Acsl6
KLA  ATP  ATP+KLA
 NM_001033599 acyl-CoA synthetase long-chain family member 6 (Acsl6), transcript variant 4, mRNA [NM_001033599] KLA .97 .99 1.02 1.02 1.00 1.01 .99
ATP 1.01 1.01 1.02 1.00 1.00 1.01 1.04
KLA/ATP .97 1.06 1.00 1.02 .94 1.00 1.02
Adipoq
KLA  ATP  ATP+KLA
 NM_009605 adiponectin, C1Q and collagen domain containing (Adipoq), mRNA [NM_009605] KLA 1.03 .99 1.01 .97 1.03 1.09 .94
ATP .98 .98 1.04 1.15 1.13 1.09 1.03
KLA/ATP 1.02 .99 1.04 1.11 1.06 1.05 1.01
AK087232
KLA  ATP  ATP+KLA
 AK087232 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030037J19 product:unclassifiable, full insert sequence. [AK087232] KLA .99 1.12 1.03 1.03 1.01 .89 1.05
ATP 1.01 1.00 1.04 1.06 1.01 1.01 .92
KLA/ATP 1.02 1.05 .97 1.00 1.05 .84 .98
Angptl4
KLA  ATP  ATP+KLA
 NM_020581 angiopoietin-like 4 (Angptl4), mRNA [NM_020581] KLA .22 .19 .16 .17 .17 .17 .17
ATP .94 .81 .90 .58 .36 .37 .30
KLA/ATP .20 .21 .24 .24 .31 .41 .33
Apoa1
KLA  ATP  ATP+KLA
 NM_009692 apolipoprotein A-I (Apoa1), mRNA [NM_009692] KLA .99 1.00 1.00 1.02 1.01 1.02 .98
ATP 1.00 1.00 1.02 1.16 1.03 1.04 1.01
KLA/ATP 1.00 1.03 1.07 1.23 1.10 1.05 .98
Apoa2
KLA  ATP  ATP+KLA
 NM_013474 apolipoprotein A-II (Apoa2), mRNA [NM_013474] KLA .94 .92 .97 .93 .92 .90 .92
ATP 1.02 1.02 1.12 .95 .90 .90 .91
KLA/ATP 1.02 .94 .97 .95 .87 .87 .86
Apoa5
KLA  ATP  ATP+KLA
 NM_080434 apolipoprotein A-V (Apoa5), mRNA [NM_080434] KLA 1.04 .98 .99 1.03 1.01 1.00 1.04
ATP 1.01 .98 .97 .98 1.02 1.01 .94
KLA/ATP 1.01 1.01 1.03 .99 .97 .98 1.02
Apoc3
KLA  ATP  ATP+KLA
 NM_023114 apolipoprotein C-III (Apoc3), mRNA [NM_023114] KLA 1.03 .99 .99 .98 1.06 .95 1.01
ATP 1.00 .99 1.05 1.02 .97 1.03 1.00
KLA/ATP 1.04 .97 1.06 1.00 .96 .99 1.00
Aqp7
KLA  ATP  ATP+KLA
 AB010100 mRNA for aquaporin 7, complete cds. [AB010100] KLA 1.05 1.17 1.00 .99 .99 .98 .99
ATP 1.07 1.04 .94 1.04 1.00 .93 1.01
KLA/ATP 1.06 1.06 .98 .99 1.03 1.01 1.05
Aqp7
KLA  ATP  ATP+KLA
 NM_007473 aquaporin 7 (Aqp7), mRNA [NM_007473] KLA .95 1.01 1.02 .97 .95 .93 .97
ATP .97 .96 1.08 1.02 1.01 .98 .97
KLA/ATP .94 1.02 1.04 .95 .96 .95 1.13
Cd36
KLA  ATP  ATP+KLA
 L23108 CD36 antigen mRNA, complete cds. [L23108] KLA .75 .74 .73 .57 .51 .40 .54
ATP .94 .93 .74 .61 .63 1.01 2.07
KLA/ATP .70 .67 .53 .47 .40 .58 1.13
Cd36
KLA  ATP  ATP+KLA
 NM_007643 CD36 antigen (Cd36), mRNA [NM_007643] KLA .70 .75 .67 .54 .45 .35 .42
ATP 1.06 1.04 .73 .58 .62 .81 1.44
KLA/ATP .83 .73 .45 .46 .35 .45 .82
Cpt1a
KLA  ATP  ATP+KLA
 NM_013495 carnitine palmitoyltransferase 1a, liver (Cpt1a), nuclear gene encoding mitochondrial protein, mRNA [NM_013495] KLA .84 .84 1.00 .93 .89 1.02 1.02
ATP 1.03 1.11 .93 .95 .67 .54 .67
KLA/ATP .92 .94 .77 .86 .77 .76 1.02
Cpt1b
KLA  ATP  ATP+KLA
 NM_009948 carnitine palmitoyltransferase 1b, muscle (Cpt1b), nuclear gene encoding mitochondrial protein, mRNA [NM_009948] KLA 1.00 1.04 1.04 1.08 1.10 1.08 .99
ATP 1.05 1.05 1.17 1.43 1.47 1.20 .84
KLA/ATP 1.09 1.06 1.13 1.37 1.77 1.29 .94
Cpt1c
KLA  ATP  ATP+KLA
 NM_153679 carnitine palmitoyltransferase 1c (Cpt1c), mRNA [NM_153679] KLA .91 .92 .92 .93 .85 .84 .76
ATP .99 1.00 .93 .94 .81 .79 .74
KLA/ATP .96 .89 .84 .88 .82 .78 .70
Cpt2
KLA  ATP  ATP+KLA
 NM_009949 carnitine palmitoyltransferase 2 (Cpt2), nuclear gene encoding mitochondrial protein, mRNA [NM_009949] KLA .92 .87 .81 .87 .78 .96 .85
ATP .95 .91 1.13 .74 .52 1.20 .94
KLA/ATP .79 .83 .96 .65 .74 1.63 1.32
Cyp27a1
KLA  ATP  ATP+KLA
 NM_024264 cytochrome P450, family 27, subfamily a, polypeptide 1 (Cyp27a1), nuclear gene encoding mitochondrial protein, mRNA [NM_024264] KLA 1.03 .98 1.22 1.00 .87 .57 .40
ATP 1.07 1.06 .99 1.18 .71 .41 .38
KLA/ATP 1.02 1.10 1.24 1.03 .72 .50 .34
Cyp4a10
KLA  ATP  ATP+KLA
 NM_010011 cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011] KLA 1.14 1.13 1.13 1.13 1.15 1.12 1.06
ATP 1.02 1.01 1.09 1.03 1.10 1.11 1.00
KLA/ATP 1.09 1.11 1.36 1.23 1.25 1.09 1.02
Cyp4a10
KLA  ATP  ATP+KLA
 X71478 gb|M.musculus Cyp4a-10 mRNA. [X71478] KLA .94 .97 .93 1.01 1.01 1.09 1.26
ATP .96 1.07 1.04 1.18 .88 .77 1.18
KLA/ATP 1.00 .99 .98 .98 .84 .80 1.24
Cyp4a12a
KLA  ATP  ATP+KLA
 NM_177406 cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406] KLA 1.08 1.04 1.02 1.06 .98 1.05 1.05
ATP .98 1.00 1.10 .99 .96 1.04 .98
KLA/ATP 1.07 1.05 1.11 .96 1.06 1.02 .97
Cyp4a12b
KLA  ATP  ATP+KLA
 NM_172306 cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306] KLA 1.03 1.05 .95 .99 .94 1.02 1.12
ATP .93 .99 .95 1.00 .93 .95 1.01
KLA/ATP .98 1.01 1.09 1.00 .90 .91 .93
Cyp4a14
KLA  ATP  ATP+KLA
 NM_007822 cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822] KLA .99 1.00 1.00 .97 .96 .97 1.01
ATP .95 .95 .93 .90 .93 .99 1.03
KLA/ATP .97 .99 1.04 .93 .95 .96 .97
Cyp4a29
KLA  ATP  ATP+KLA
 NM_001100183 cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183] KLA .94 .98 1.04 1.00 .98 1.06 1.03
ATP 1.01 1.02 1.03 1.02 1.01 1.02 .97
KLA/ATP 1.05 1.09 1.03 1.03 .97 1.02 .91
Cyp4a31
KLA  ATP  ATP+KLA
 NM_201640 cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640] KLA 1.14 .99 1.00 .98 1.06 1.03 .96
ATP 1.01 1.05 1.04 .91 .98 .99 .99
KLA/ATP .99 1.03 1.04 .99 .95 .97 1.06
Cyp7a1
KLA  ATP  ATP+KLA
 NM_007824 cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1), mRNA [NM_007824] KLA 1.03 .99 .97 1.00 .97 1.03 .99
ATP .99 .99 1.02 1.04 .99 .99 1.03
KLA/ATP 1.03 1.00 .99 .99 .91 .97 .99
Cyp8b1
KLA  ATP  ATP+KLA
 NM_010012 cytochrome P450, family 8, subfamily b, polypeptide 1 (Cyp8b1), mRNA [NM_010012] KLA .98 1.06 1.04 1.00 1.03 1.03 1.06
ATP 1.00 .99 1.02 1.04 1.06 1.01 1.09
KLA/ATP 1.08 .99 1.05 1.19 1.11 1.11 1.01
Dbi
KLA  ATP  ATP+KLA
 NM_001037999 diazepam binding inhibitor (Dbi), transcript variant 1, mRNA [NM_001037999] KLA 1.08 1.11 1.07 1.02 .91 .80 .58
ATP .94 .98 1.17 1.49 2.04 2.07 1.07
KLA/ATP 1.05 1.15 1.19 1.30 1.72 1.94 .73
Ehhadh
KLA  ATP  ATP+KLA
 NM_023737 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase (Ehhadh), mRNA [NM_023737] KLA .74 .77 .80 .88 .71 .67 .74
ATP 1.02 1.06 1.04 .90 .70 .84 .83
KLA/ATP .79 .81 .80 .65 .59 .79 .55
Fabp1
KLA  ATP  ATP+KLA
 NM_017399 fatty acid binding protein 1, liver (Fabp1), mRNA [NM_017399] KLA 1.07 1.05 1.02 .97 1.02 1.00 1.02
ATP 1.04 1.04 1.06 .99 .99 .97 .90
KLA/ATP .96 1.03 1.02 .99 .94 .97 .94
Fabp2
KLA  ATP  ATP+KLA
 NM_007980 fatty acid binding protein 2, intestinal (Fabp2), mRNA [NM_007980] KLA 1.87 1.96 2.32 1.82 2.37 1.80 1.89
ATP 1.05 1.10 1.03 1.26 1.09 1.07 1.37
KLA/ATP 2.04 2.14 1.41 1.96 1.38 1.34 1.69
Fabp3
KLA  ATP  ATP+KLA
 NM_010174 fatty acid binding protein 3, muscle and heart (Fabp3), mRNA [NM_010174] KLA 2.59 2.44 2.66 4.07 4.42 7.11 4.45
ATP .96 1.02 1.49 2.44 4.73 7.63 3.26
KLA/ATP 2.47 2.61 4.71 8.15 10.83 13.30 9.93
Fabp4
KLA  ATP  ATP+KLA
 NM_024406 fatty acid binding protein 4, adipocyte (Fabp4), mRNA [NM_024406] KLA 1.84 1.76 1.66 1.39 .73 .81 1.74
ATP .95 .93 1.71 3.08 5.65 4.30 4.25
KLA/ATP 1.79 1.94 2.98 3.86 4.69 5.79 2.85
Fabp5
KLA  ATP  ATP+KLA
 X70100 gb|M.musculus mal1 mRNA for keratinocyte lipid-binding protein. [X70100] KLA .93 .90 .94 .90 .79 .79 1.46
ATP 1.01 1.06 1.31 1.64 1.49 1.11 3.29
KLA/ATP .94 1.01 1.20 1.49 1.38 1.12 .83
Fabp6
KLA  ATP  ATP+KLA
 NM_008375 fatty acid binding protein 6, ileal (gastrotropin) (Fabp6), mRNA [NM_008375] KLA 1.02 .95 .83 1.03 .99 1.04 1.04
ATP .98 1.00 .93 .96 .96 .89 .95
KLA/ATP .99 1.04 1.00 .99 .95 1.00 .99
Fabp7
KLA  ATP  ATP+KLA
 NM_021272 fatty acid binding protein 7, brain (Fabp7), mRNA [NM_021272] KLA 1.65 1.64 1.58 2.31 2.15 3.27 4.62
ATP .97 .89 1.55 1.54 1.59 2.59 5.05
KLA/ATP 1.66 1.89 2.66 2.44 2.43 2.62 6.90
Fads2
KLA  ATP  ATP+KLA
 NM_019699 fatty acid desaturase 2 (Fads2), mRNA [NM_019699] KLA .84 .82 .87 .71 .55 .37 .31
ATP 1.04 1.10 1.03 1.27 .98 .58 .49
KLA/ATP .84 .83 .86 .97 .72 .44 .23
Gk2
KLA  ATP  ATP+KLA
 NM_010294 glycerol kinase 2 (Gk2), mRNA [NM_010294] KLA 1.26 1.28 1.65 1.55 1.96 1.59 1.41
ATP .99 1.02 1.00 1.17 1.20 1.63 1.06
KLA/ATP 1.39 1.49 1.34 1.36 1.21 1.45 1.30
Gyk
KLA  ATP  ATP+KLA
 AK037633 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130030N17 product:unclassifiable, full insert sequence [AK037633] KLA 5.44 4.98 5.36 4.61 4.88 2.89 1.97
ATP 1.17 1.65 4.22 2.33 6.88 2.27 1.07
KLA/ATP 5.99 9.29 15.97 4.69 3.09 3.74 2.06
Gyk
KLA  ATP  ATP+KLA
 AK086200 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930012N15 product:glycerol kinase, full insert sequence. [AK086200] KLA 1.16 1.08 1.12 1.03 1.02 1.07 .98
ATP .93 1.01 1.12 .95 1.14 .96 .98
KLA/ATP 1.23 1.24 1.22 .95 1.10 .96 1.06
Gyk
KLA  ATP  ATP+KLA
 NM_008194 glycerol kinase (Gyk), transcript variant 1, mRNA [NM_008194] KLA 2.56 2.95 3.62 4.16 5.93 5.02 2.77
ATP 1.04 1.19 1.02 1.51 2.16 4.68 1.09
KLA/ATP 2.65 2.96 2.71 4.15 2.62 4.18 3.09
Gyk
KLA  ATP  ATP+KLA
 NM_212444 glycerol kinase (Gyk), transcript variant 2, mRNA [NM_212444] KLA 3.95 4.35 5.39 5.59 8.90 6.88 3.32
ATP 1.12 1.38 1.20 1.70 2.32 4.01 .95
KLA/ATP 3.99 4.03 4.00 5.56 2.86 3.73 3.14
Hmgcs2
KLA  ATP  ATP+KLA
 NM_008256 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (Hmgcs2), nuclear gene encoding mitochondrial protein, mRNA [NM_008256] KLA .92 1.10 1.00 .99 1.08 1.06 1.14
ATP .99 1.02 1.00 1.00 .98 1.08 .92
KLA/ATP .99 1.00 1.00 1.03 1.28 1.06 1.00
Ilk
KLA  ATP  ATP+KLA
 NM_010562 integrin linked kinase (Ilk), mRNA [NM_010562] KLA .84 .85 .92 .81 .97 .96 .67
ATP 1.03 1.11 .85 1.07 .82 .66 .91
KLA/ATP .93 .90 .58 .94 .63 .63 .80
Lpl
KLA  ATP  ATP+KLA
 NM_008509 lipoprotein lipase (Lpl), mRNA [NM_008509] KLA .81 .81 .89 .76 .77 .71 .76
ATP 1.10 1.07 .65 .45 .37 .24 .62
KLA/ATP .89 .90 .56 .40 .29 .21 .23
Me1
KLA  ATP  ATP+KLA
 NM_008615 malic enzyme 1, NADP(+)-dependent, cytosolic (Me1), mRNA [NM_008615] KLA .95 1.01 1.01 .81 .71 .71 1.97
ATP .94 1.03 1.19 1.09 .93 1.48 .67
KLA/ATP .98 .96 1.04 .89 .65 .87 1.05
Mm.10984
KLA  ATP  ATP+KLA
 6678010 Unknown KLA .98 1.03 .96 1.03 .98 .98 .98
ATP .96 .96 1.01 1.06 .93 .93 .93
KLA/ATP .96 .93 .84 .93 1.08 1.19 1.04
Mm.17942
1
KLA  ATP  ATP+KLA
 84993735 Unknown KLA .93 1.00 1.05 1.00 .99 1.01 1.01
ATP 1.02 1.03 1.03 1.05 1.08 .98 1.01
KLA/ATP 1.05 .97 1.04 .99 1.09 1.10 1.00
Mm.25851
7
KLA  ATP  ATP+KLA
 124487284 Unknown KLA .95 .94 .97 .94 .87 .88 .75
ATP 1.05 1.00 .95 .94 1.01 .99 .85
KLA/ATP 1.01 .86 .84 .87 1.03 1.03 .83
Mm.29150
3
KLA  ATP  ATP+KLA
 34328333 Unknown KLA .61 .60 .60 .53 .51 .56 .69
ATP 1.05 .96 .93 .75 .81 .44 .78
KLA/ATP .66 .58 .67 .52 .58 .47 .55
Mm.29362
6
KLA  ATP  ATP+KLA
 134053880 Unknown KLA 7.23 6.16 6.71 5.06 3.81 2.61 1.75
ATP 1.14 1.34 2.13 3.36 9.90 10.36 1.64
KLA/ATP 7.23 8.21 6.94 6.55 5.27 5.68 3.35
Mm.37812
8
KLA  ATP  ATP+KLA
 162139826 Unknown KLA .94 .92 .89 .82 .67 .71 1.85
ATP .88 .91 1.28 .99 .92 1.81 .61
KLA/ATP .85 .89 1.10 .81 .72 .96 1.14
Mm.44829
2
KLA  ATP  ATP+KLA
 86198313 Unknown KLA 1.12 1.03 1.02 1.14 1.04 1.07 1.02
ATP .95 .98 1.18 1.06 1.12 1.07 1.04
KLA/ATP 1.04 1.15 1.29 1.11 1.16 1.21 1.14
Mm.46661
0
KLA  ATP  ATP+KLA
 82894546 Unknown KLA .86 .90 .99 .94 1.02 .83 .91
ATP 1.10 1.04 1.04 1.15 1.03 .93 .84
KLA/ATP .86 .85 1.00 1.10 .94 .85 .90
Mmp1a
KLA  ATP  ATP+KLA
 NM_032006 matrix metallopeptidase 1a (interstitial collagenase) (Mmp1a), mRNA [NM_032006] KLA 1.02 1.04 1.01 1.00 1.05 1.04 1.09
ATP .93 .99 1.07 1.13 1.04 1.05 1.05
KLA/ATP 1.01 1.02 .88 1.01 1.05 1.03 .98
Nr1h3
KLA  ATP  ATP+KLA
 NM_013839 nuclear receptor subfamily 1, group H, member 3 (Nr1h3), mRNA [NM_013839] KLA 1.80 1.74 1.73 2.19 4.14 5.99 8.67
ATP 1.12 .93 .69 .83 1.14 1.09 2.92
KLA/ATP 1.86 1.77 1.13 1.15 1.44 1.38 6.71
Olr1
KLA  ATP  ATP+KLA
 NM_138648 oxidized low density lipoprotein (lectin-like) receptor 1 (Olr1), mRNA [NM_138648] KLA 9.12 7.68 5.64 4.63 2.87 1.85 1.54
ATP 1.02 1.09 1.74 2.37 13.70 19.09 1.53
KLA/ATP 8.82 9.30 6.77 5.14 4.08 4.72 2.37
Pck2
KLA  ATP  ATP+KLA
 NM_028994 phosphoenolpyruvate carboxykinase 2 (mitochondrial) (Pck2), nuclear gene encoding mitochondrial protein, mRNA [NM_028994] KLA .40 .37 .32 .28 .37 .56 .55
ATP .99 .96 .86 .94 1.02 .57 .77
KLA/ATP .40 .37 .31 .35 .42 .35 .46
Pdpk1
KLA  ATP  ATP+KLA
 NM_011062 3-phosphoinositide dependent protein kinase-1 (Pdpk1), transcript variant 1, mRNA [NM_011062] KLA .90 .90 .84 1.00 1.32 1.19 1.15
ATP 1.05 1.09 1.04 1.14 1.31 .97 1.17
KLA/ATP .90 .89 .91 1.02 1.27 .96 1.42
Plin
KLA  ATP  ATP+KLA
 NM_175640 perilipin (Plin), transcript variant 1, mRNA [NM_175640] KLA .99 1.02 1.02 1.03 1.01 1.04 1.04
ATP 1.01 1.03 1.08 1.00 1.00 .98 1.06
KLA/ATP 1.04 .91 .96 1.02 1.01 1.12 1.05
Pltp
KLA  ATP  ATP+KLA
 NM_011125 phospholipid transfer protein (Pltp), mRNA [NM_011125] KLA .85 .94 1.03 .87 1.22 1.33 1.52
ATP 1.13 1.35 .72 1.42 .89 .61 .64
KLA/ATP 1.10 1.12 .59 1.26 .62 .69 .82
Ppara
KLA  ATP  ATP+KLA
 NM_011144 peroxisome proliferator activated receptor alpha (Ppara), transcript variant 1, mRNA [NM_011144] KLA 1.01 3.31 .99 1.02 1.00 1.00 .98
ATP 1.00 1.02 .99 1.00 1.00 1.00 1.01
KLA/ATP 1.01 1.01 1.02 .99 1.00 1.02 .99
Ppard
KLA  ATP  ATP+KLA
 NM_011145 peroxisome proliferator activator receptor delta (Ppard), mRNA [NM_011145] KLA 1.04 .97 1.09 1.04 1.14 .99 1.11
ATP 1.03 .97 .94 1.01 1.36 1.49 1.11
KLA/ATP 1.00 1.00 .94 1.07 1.20 1.29 1.17
Pparg
KLA  ATP  ATP+KLA
 NM_011146 peroxisome proliferator activated receptor gamma (Pparg), mRNA [NM_011146] KLA .32 .28 .31 .45 .38 .35 .49
ATP .96 1.01 1.28 1.65 1.83 .57 .77
KLA/ATP .30 .29 .36 .53 1.23 .72 .55
Rxra
KLA  ATP  ATP+KLA
 NM_011305 retinoid X receptor alpha (Rxra), mRNA [NM_011305] KLA .53 .55 .50 .52 .54 .85 1.09
ATP .95 1.00 1.18 1.00 .82 1.20 1.65
KLA/ATP .57 .55 .58 .55 .67 1.07 1.57
Rxrb
KLA  ATP  ATP+KLA
 NM_011306 retinoid X receptor beta (Rxrb), mRNA [NM_011306] KLA .71 .75 .75 .76 .83 .81 .89
ATP 1.04 1.13 .94 1.20 1.13 .81 .75
KLA/ATP .80 .86 .72 .85 .83 .93 .92
Rxrg
KLA  ATP  ATP+KLA
 NM_009107 retinoid X receptor gamma (Rxrg), mRNA [NM_009107] KLA .98 1.07 1.07 1.00 1.00 1.00 1.07
ATP 1.02 1.03 1.06 1.06 1.11 1.01 .99
KLA/ATP .95 .97 1.05 1.05 1.09 .98 1.06
Scd1
KLA  ATP  ATP+KLA
 NM_009127 stearoyl-Coenzyme A desaturase 1 (Scd1), mRNA [NM_009127] KLA .79 .81 .86 .72 .59 .43 .33
ATP .97 .87 .82 .75 .68 .62 .72
KLA/ATP .78 .74 .67 .68 .54 .45 .28
Scd2
KLA  ATP  ATP+KLA
 NM_009128 stearoyl-Coenzyme A desaturase 2 (Scd2), mRNA [NM_009128] KLA .10 .08 .08 .07 .11 .19 .48
ATP 1.02 .63 .27 .13 .12 .33 .59
KLA/ATP .09 .06 .05 .04 .05 .06 .07
Scd3
KLA  ATP  ATP+KLA
 NM_024450 stearoyl-coenzyme A desaturase 3 (Scd3), mRNA [NM_024450] KLA 1.06 1.01 1.07 1.08 1.14 1.21 1.43
ATP 1.02 1.04 1.06 1.02 1.06 1.03 1.07
KLA/ATP 1.06 1.06 .96 1.10 1.19 1.15 1.30
Scd4
KLA  ATP  ATP+KLA
 BC038322 stearoyl-coenzyme A desaturase 4, mRNA (cDNA clone IMAGE:1479917), complete cds. [BC038322] KLA .95 1.03 1.02 1.01 .94 1.07 1.09
ATP 1.03 1.03 1.07 1.04 1.06 1.03 1.04
KLA/ATP 1.03 1.00 1.09 1.06 1.06 1.10 1.06
Scd4
KLA  ATP  ATP+KLA
 NM_183216 stearoyl-coenzyme A desaturase 4 (Scd4), mRNA [NM_183216] KLA 1.01 .97 .92 .93 .92 .94 .89
ATP .97 1.01 .98 .91 .86 1.03 1.00
KLA/ATP .96 .90 1.02 .94 .97 .86 .89
Scp2
KLA  ATP  ATP+KLA
 NM_011327 sterol carrier protein 2, liver (Scp2), mRNA [NM_011327] KLA .88 .85 .85 .77 .71 .68 .66
ATP 1.03 1.13 1.25 1.38 1.10 .63 .47
KLA/ATP .85 .88 .91 1.06 .83 .58 .38
Slc27a1
KLA  ATP  ATP+KLA
 AK165571 kidney CCL-142 RAG cDNA, RIKEN full-length enriched library, clone:G430020K07 product:solute carrier family 27 (fatty acid transporter), member 1, full insert sequence [AK165571] KLA .44 .36 .31 .37 .58 1.08 .86
ATP 1.06 .93 .89 .70 .60 .38 1.25
KLA/ATP .37 .35 .32 .28 .33 .29 .89
Slc27a1
KLA  ATP  ATP+KLA
 NM_011977 solute carrier family 27 (fatty acid transporter), member 1 (Slc27a1), mRNA [NM_011977] KLA .53 .53 .53 .48 .67 .99 1.18
ATP 1.04 1.17 .72 1.04 .75 .39 1.88
KLA/ATP .64 .62 .32 .56 .40 .42 1.68
Slc27a2
KLA  ATP  ATP+KLA
 AK038847 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230068F22 product:solute carrier family 27 (fatty acid transporter), member 2, full insert sequence. [AK038847] KLA .99 .98 1.13 .98 1.04 .98 .99
ATP .98 1.05 1.32 .96 .96 1.07 1.01
KLA/ATP 1.06 .98 1.02 1.01 .96 1.03 1.07
Slc27a2
KLA  ATP  ATP+KLA
 NM_011978 solute carrier family 27 (fatty acid transporter), member 2 (Slc27a2), mRNA [NM_011978] KLA 1.26 1.26 1.24 1.22 1.14 1.00 .85
ATP .98 1.06 1.04 .95 .99 1.07 1.06
KLA/ATP 1.24 1.16 1.34 1.12 1.01 .97 1.11
Slc27a4
KLA  ATP  ATP+KLA
 NM_011989 solute carrier family 27 (fatty acid transporter), member 4 (Slc27a4), mRNA [NM_011989] KLA .94 .93 .97 .87 .91 .97 1.23
ATP 1.05 1.02 .82 .75 .76 1.73 1.49
KLA/ATP 1.05 1.01 .78 .82 .75 1.31 2.26
Slc27a5
KLA  ATP  ATP+KLA
 NM_009512 solute carrier family 27 (fatty acid transporter), member 5 (Slc27a5), mRNA [NM_009512] KLA .94 .95 .95 1.02 1.03 .97 1.02
ATP 1.03 .95 1.04 1.10 .97 .91 1.00
KLA/ATP 1.06 .96 .94 .99 1.04 1.01 1.04
Slc27a6
KLA  ATP  ATP+KLA
 NM_001081072 solute carrier family 27 (fatty acid transporter), member 6 (Slc27a6), mRNA [NM_001081072] KLA 1.02 .94 .96 .92 .95 .97 .89
ATP 1.03 1.02 .97 .96 .93 .97 .93
KLA/ATP .99 .91 .96 .98 .93 .96 .73
Sorbs1
KLA  ATP  ATP+KLA
 NM_178362 sorbin and SH3 domain containing 1 (Sorbs1), transcript variant 2, mRNA [NM_178362] KLA .92 .85 .90 .76 .93 .86 .86
ATP .96 1.02 .95 .73 .70 1.05 .79
KLA/ATP .86 .85 .93 .70 .74 1.25 1.40
Ubc
KLA  ATP  ATP+KLA
 NM_019639 ubiquitin C (Ubc), mRNA [NM_019639] KLA 1.16 1.23 1.58 1.88 2.47 1.98 2.13
ATP 1.15 1.33 1.86 3.49 1.39 .90 1.89
KLA/ATP 1.38 1.37 1.21 2.46 2.05 1.72 3.73
Ucp1
KLA  ATP  ATP+KLA
 NM_009463 uncoupling protein 1 (mitochondrial, proton carrier) (Ucp1), nuclear gene encoding mitochondrial protein, mRNA [NM_009463] KLA 1.06 1.04 .96 1.18 1.07 1.24 1.08
ATP .97 .96 1.33 4.92 4.96 3.59 1.36
KLA/ATP 1.06 1.01 1.33 7.52 10.87 7.27 3.86